COMPASS THERAPEUTICS, INC.
Profile
Company Names
COMPASS THERAPEUTICS, INC.
Addresses
245 FIRST STREET, 3RD FLOOR, CAMBRIDGE, MA 02142
Phone Numbers
617-500-8099
Entity Type:
CORPORATION
Industry:
OTHER
Year Incorporated:
2018
State Incorporated:
DELAWARE
Total Amount Raised:
$255,758,990.00
Number of Funding Rounds:
2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2020-06-19
$60,482,210.00
$70,000,000.00
$9,517,790.00
Equity
1
2020-06-17
$195,276,780.00
$195,276,780.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
VERED
BISKER-LEIB
EXECUTIVE OFFICER
PHILIP
FERNEAU
DIRECTOR
CARL
L.
GORDON
DIRECTOR
CADUCEUS PRIVATE INVESTMENTS IV, LP
| AMARIN CORP PLC\UK
| SELECTA BIOSCIENCES INC
| CADUCEUS CAPITAL II, L.P.
| CADUCEUS CAPITAL, L.P.
| ORBIMED ISRAEL PARTNERS LIMITED PARTNERSHIP
| ACCELERON PHARMA INC
| SINGULEX INC
| SINGULEX, INC.
| ORBIMED PARTNERS II, L.P.
| ORBIMED PARTNERS, L.P.
| ORBIMED PRIVATE INVESTMENTS V, LP
| ORBIMED GLOBAL HEALTHCARE ASSOCIATES FUND, L.P.
| ORBIMED GLOBAL HEALTHCARE FUND, L.P.
| ORBIMED ROYALTY OPPORTUNITIES II, LP
| ORBIMED ASIA PARTNERS III, L.P.
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES III, LP
| ORBIMED GENESIS FUND, L.P.
| ORBIMED NEW HORIZONS FUND, L.P.
| COMPASS THERAPEUTICS, INC.
| ORBIMED ASIA PARTNERS IV, L.P.
| ORBIMED ASIA PARTNERS V, L.P.
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES IV, LP
| ORBIMED RCO IV OFFSHORE FEEDER, LP
| ORBIMED PRIVATE INVESTMENTS IX, LP
| ORBIMED RCO V OFFSHORE FEEDER, LP
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES V, LP
| ORBIMED ASIA PARTNERS VI, L.P.
JULIE
SUNDERLAND
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2020-06-17
D
OTHER
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2020-06-19
